S&S Dinner Dialogues: Dr. Jessie Tenenbaum
De-Identified Clinical Data in the Genomic Era
US law permits secondary use of de-identified clinical data for research purposes without a patient's knowledge or consent. But biospecimens, and genomic sequence data derived from them, are increasingly linked to clinical data in the era of genomic and precision medicine. What are the risks involved, and where should the limits lie?
Duke University students, post-doctoral fellows, researchers, and faculty are invited to attend. RSVP required: http://duke.is/RcXNTY